Table of Contents
Introduction
The Success of Traditional Pathway Studies
The Need for New Pathway-Based Knowledge and Approaches
Elucidating Signaling Pathways and Identifying Drug Targets
- Technologies
- Yeast Two-Hybrid Assay
- Tandem Affinity Purification
- RNAi
- Strategies
- Cellzome's Study of the TNF-ƒ¿/NF-ƒÈB Signal Transduction Pathway
- Hybrigenics' Study of Signal Transduction Pathways in Drosophila
Pathway-Based Drug Screening Technologies and Strategies
- BioImage's Redistribution Technology
- Bionaut's Sentinel Line Technology
- BioSeek's BioMAP Systems
- Avalon Pharmaceuticals' Pathology-Based Screens
Novartis's Pathway-Based Drug Discovery Strategy
Corporate Highlights
- Bionaut Pharmaceuticals
- BioSeek
- Cellzome
- BioImage
- Hybrigenics
Outlook for Pathway-Based Drug Discovery
|